JPMORGAN CHASE & CO - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 35 filers reported holding HAEMONETICS CORP MASS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q1 2023$1,972,000
+32948.4%
2,317,000
-67.7%
0.00%
-100.0%
Q4 2022$5,967
-99.9%
7,169,000
+2.5%
0.00%0.0%
Q3 2022$5,607,000
+17.4%
6,994,000
+16.0%
0.00%0.0%
Q2 2022$4,774,000
+44.1%
6,031,000
+53.3%
0.00%
Q1 2022$3,312,0003,934,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 48,416$41,563,0002.83%
HPS Investment Partners, LLC 5,419$4,567,0001.76%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,169,0000.83%
ADVENT CAPITAL MANAGEMENT /DE/ 48,979,000$41,243,0000.66%
Aequim Alternative Investments LP 20,500,000$17,276,0000.46%
Kohlberg Kravis Roberts & Co. L.P. 45,394,000$38,255,0000.35%
Quaero Capital S.A. 900,000$757,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 21,614,000$18,214,0000.19%
Brandywine Global Investment Management, LLC 29,515,000$24,873,0000.18%
AVIVA PLC 38,300,000$32,126,0000.16%
View complete list of HAEMONETICS CORP MASS shareholders